Integrated Sustainability Report

Overview

The report presents the company's second Integrated Sustainability Report, covering 2024 financial and non-financial performance across EIS and key subsidiaries. It introduces the first double materiality analysis for Gensenta and Eczacıbaşı Pharmaceuticals Marketing, combining impact and financial materiality. Climate highlights include a 52% reduction in Scope 1 and 2 emissions versus the 2021 base year, 46,430 MWh of total energy consumption and 53% renewable energy. Social highlights include 1,307 employees, 39% women among professional employees and 35% women in management.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview